The Journal of Allergy and Clinical Immunology
Volume 124, Issue 2 , Pages 278-285.e7, August 2009

Exploring the repertoire of IgE-binding self-antigens associated with atopic eczema

  • Sabine Zeller, MSc

      Affiliations

    • Swiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Davos, Switzerland
  • ,
  • Claudio Rhyner, PhD

      Affiliations

    • Swiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Davos, Switzerland
  • ,
  • Norbert Meyer, MD

      Affiliations

    • Swiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Davos, Switzerland
    • Deutsche Hochgebirgsklinik, Davos-Wolfgang, Switzerland
  • ,
  • Peter Schmid-Grendelmeier, MD

      Affiliations

    • Allergy Unit, Department of Dermatology, University Hospital of Zurich, Zurich, Switzerland
  • ,
  • Cezmi A. Akdis, MD

      Affiliations

    • Swiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Davos, Switzerland
  • ,
  • Reto Crameri, PhD

      Affiliations

    • Swiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Davos, Switzerland
    • Corresponding Author InformationReprint requests: Reto Crameri, PhD, Molecular Allergology, Swiss Institute of Allergy and Asthma Research (SIAF), Obere Str. 22, CH-7270 Davos Platz, Switzerland.

Received 7 January 2009; received in revised form 11 May 2009; accepted 13 May 2009. published online 22 June 2009.

Background

Atopic eczema (AE) is the most common chronic inflammatory skin disease. Recent data demonstrate the presence of autoreactive serum IgE antibodies correlating with the severity of the disease.

Objective

Although several IgE-binding self-antigens have been reported, the whole repertoire of IgE-binding self-antigens is unknown. We aimed to estimate the repertoire size of autoreactive proteins related to AE and clone, produce, and characterize humoral and T-cell responses against novel self-antigens.

Methods

Phage surface–displayed human cDNA libraries were enriched for clones binding to serum IgE from patients with AE and screened by using high-throughput technology. Selected clones were used to produce the encoded proteins, to test their IgE-binding ability in Western blots and ELISAs, and their ability to induce mediator release from basophils of sensitized individuals.

Results

One hundred forty sequences encoding potential IgE-binding self-antigens associated with AE were identified. Sixteen sequences encoded already described self-antigens. Three new sequences showed homology with environmental allergens, 86 encoded known human proteins, 7 predicted proteins, and 28 showed sequence identity with genomic contigs. Immunoblotting and ELISA experiments demonstrated the presence of IgE antibodies in sera from patients with AE to 5 selected recombinant self-antigens and their ability to induce mediator release from basophils of patients with AE who have self-antigen–specific IgE antibodies.

Conclusion

These data demonstrate a broad spectrum of at least 140 IgE-binding self-antigens associated with AE. By binding IgE antibodies or activating specific T cells, they might promote, perpetuate, or both existing skin inflammation.

Key words: Atopic eczema, autoreactivity, self-antigens, IgE, mediator release, atopic dermatitis

Abbreviations used: AE, Atopic eczema, AP, Alkaline phosphatase, eIF6, Eukaryotic translation initiation factor 6, Hom s, Homo sapiens IgE-binding self-antigens, MnSOD, Manganese superoxide dismutase, ORF, Open reading frame

 

 Supported by Swiss National Science Foundation grants 31-63381.00/2 and 310000-114634/1 and by the OPO-Pharma Foundation, Zurich, Switzerland.

 Disclosure of potential conflict of interest: C. A. Akdis receives grant support from the Swiss National Foundation, AllergoPharma Joachim-Ganzer KG, Stallergenes, Imvision, and Novartis; is Vice President of the European Academy of Allergology and Clinical Immunology; is an excommittee member, representative of Switzerland, and assembly member of GA2LEN; and is a fellow of the American Academy of Allergy, Asthma & Immunology.

PII: S0091-6749(09)00807-0

doi:10.1016/j.jaci.2009.05.015

The Journal of Allergy and Clinical Immunology
Volume 124, Issue 2 , Pages 278-285.e7, August 2009